{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:39:12Z","timestamp":1774899552611,"version":"3.50.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ijcard.2016.02.035","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T20:45:27Z","timestamp":1454532327000},"page":"226-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The role of anti-myosin antibodies in perpetuating cardiac damage following myocardial infarction"],"prefix":"10.1016","volume":"209","author":[{"given":"Tom J.","family":"O'Donohoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan G.","family":"Schrale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natkunam","family":"Ketheesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2016.02.035_bb0005","first-page":"ii3","article-title":"Heart failure post-myocardial infarction: a review of the issues","volume":"91","author":"Dargie","year":"2005","journal-title":"Heart"},{"issue":"Suppl. P","key":"10.1016\/j.ijcard.2016.02.035_bb0010","first-page":"P9","article-title":"Clinical epidemiology of heart failure: public and private health burden","volume":"19","author":"McMurray","year":"1998","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1388-9842(00)00141-0","article-title":"More 'malignant' than cancer? Five-year survival following a first admission for heart failure","volume":"3","author":"Stewart","year":"2001","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nmat776","article-title":"The myosin coiled-coil is a truly elastic protein structure","volume":"1","author":"Schwaiger","year":"2002","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4137\/BBI.S8451","article-title":"Structural and functional insights on the myosin superfamily","volume":"6","author":"Syamaladevi","year":"2012","journal-title":"Bioinf. Biol. Insights"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0030","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/01.CIR.85.5.1734","article-title":"Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy","volume":"85","author":"Caforio","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0090-1229(90)90039-S","article-title":"A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction","volume":"57","author":"Kodama","year":"1990","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0040","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.4049\/jimmunol.139.11.3630","article-title":"Cardiac myosin induces myocarditis in genetically predisposed mice","volume":"139","author":"Neu","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9440(10)64373-8","article-title":"Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis","volume":"160","author":"Galvin","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0050","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1172\/JCI116909","article-title":"Cardiac alpha-myosin heavy chains differ in their induction of myocarditis. Identification of pathogenic epitopes","volume":"92","author":"Liao","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0735-1097(94)90513-4","article-title":"Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis","volume":"23","author":"Lauer","year":"1994","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0060","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1540-8167.1998.tb00942.x","article-title":"Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation","volume":"9","author":"Maixent","year":"1998","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0065","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0002-9149(99)00883-8","article-title":"Prevalence of autoantibodies against contractile proteins in coronary artery disease and their clinical implications","volume":"85","author":"Dangas","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02887674","article-title":"Effect of anti-cardiac myosin antibody on prognosis of patients with acute myocardial infarction","volume":"20","author":"Pang","year":"2000","journal-title":"J. Tongji Med. Univ."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003551","article-title":"Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes","volume":"4","author":"Gottumukkala","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0080","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/hrt.74.6.598","article-title":"Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy","volume":"74","author":"Goldman","year":"1995","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/bbrc.1999.0761","article-title":"Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients","volume":"259","author":"Warraich","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0090","first-page":"499","article-title":"Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy","volume":"116","author":"Wang","year":"2003","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0095","first-page":"61","article-title":"Clinical significance of antibodies against tropomyosin, actin and myosin in patients with dilated cardiomyopathy","volume":"40","author":"Konstadoulakis","year":"1993","journal-title":"J. Clin. Lab. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0100","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.4049\/jimmunol.143.8.2677","article-title":"Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein","volume":"143","author":"Cunningham","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0105","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/INF.0b013e31823058dd","article-title":"Cardiac myosin epitopes for monitoring progression of rheumatic fever","volume":"30","author":"Gorton","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0110","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4049\/jimmunol.163.2.1060","article-title":"Anti-human cardiac myosin autoantibodies in Kawasaki syndrome","volume":"163","author":"Cunningham","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0115","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9149(85)91024-0","article-title":"Post-cardiac injury syndrome and an increased humoral immune response against the major contractile proteins (actin and myosin)","volume":"56","author":"De Scheerder","year":"1985","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0120","article-title":"Diagnostic relevance of humoral and cell mediated immune reaction in patients with acute viral myocarditis","volume":"48","author":"Maisch","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0735-1097(99)00485-4","article-title":"Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis","volume":"35","author":"Lauer","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/oxfordjournals.eurheartj.a015230","article-title":"Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The myocarditis treatment trial investigators","volume":"18","author":"Caforio","year":"1997","journal-title":"Eur. Heart J."},{"issue":"Suppl. O","key":"10.1016\/j.ijcard.2016.02.035_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/eurheartj\/16.suppl_O.68","article-title":"Organ-specific cardiac autoantibodies in dilated cardiomyopathy\u2014an update","volume":"16","author":"Caforio","year":"1995","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/hrt.77.1.62","article-title":"Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression","volume":"77","author":"Caforio","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/08916938909034359","article-title":"Anti-myosin humoral immune response following cardiac injury","volume":"4","author":"De Scheerder","year":"1989","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/eurheartj\/12.suppl_D.88","article-title":"Humoral immune response against contractile proteins (actin and myosin) during cardiovascular disease","volume":"12","author":"De Scheerder","year":"1991","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1067\/mlc.2001.116489","article-title":"Interplay of antibody and T cell responses in acute myocardial infarction","volume":"138","author":"Elahi","year":"2001","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0160","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/08916930802031579","article-title":"Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies","volume":"41","author":"Mascaro-Blanco","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0165","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.4049\/jimmunol.172.5.3225","article-title":"Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat","volume":"172","author":"Li","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0170","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/clc.20356","article-title":"A prior myocardial infarction: how does it affect management and outcomes in recurrent acute coronary syndromes?","volume":"31","author":"Motivala","year":"2008","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0175","doi-asserted-by":"crossref","first-page":"206039","DOI":"10.1155\/2013\/206039","article-title":"Danger signals in the initiation of the inflammatory response after myocardial infarction","volume":"2013","author":"de Haan","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0180","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/eci.12118","article-title":"Targeting inflammatory pathways in myocardial infarction","volume":"43","author":"Christia","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0185","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2011.38","article-title":"Innate immune signaling in cardiac ischemia","volume":"8","author":"Arslan","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0190","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCRESAHA.111.243170","article-title":"Inflammation in myocardial diseases","volume":"110","author":"Marchant","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0195","first-page":"455","article-title":"IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory response","volume":"21","author":"Diepenhorst","year":"2012","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0200","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/cvr\/cvq141","article-title":"Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction","volume":"87","author":"Haas","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.iy.11.040193.001555","article-title":"T cell-dependent B cell activation","volume":"11","author":"Parker","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ni.1794","article-title":"Checkpoints in lymphocyte development and autoimmune disease","volume":"11","author":"von Boehmer","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri798","article-title":"T-cell development and the CD4\u2013CD8 lineage decision","volume":"2","author":"Germain","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0220","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1172\/JCI44583","article-title":"Impaired thymic tolerance to alpha-myosin directs autoimmunity to the heart in mice and humans","volume":"121","author":"Lv","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0225","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1034\/j.1600-065X.2000.00607.x","article-title":"B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms","volume":"176","author":"Vos","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0230","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1128\/JVI.72.8.6665-6670.1998","article-title":"T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles","volume":"72","author":"Szomolanyi-Tsuda","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0235","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.20052036","article-title":"T-independent type II immune responses generate memory B cells","volume":"203","author":"Obukhanych","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0240","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2249.1999.00807.x","article-title":"IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease","volume":"115","author":"Skyllouriotis","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.111.243360","article-title":"Autoantibodies in heart failure and cardiac dysfunction","volume":"110","author":"Kaya","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0250","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.89.19.9131","article-title":"Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis","volume":"89","author":"Smith","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002510050466","article-title":"Genetic control of autoimmune myocarditis mediated by myosin-specific antibodies","volume":"49","author":"Kuan","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.86.3.281","article-title":"Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naive mice","volume":"86","author":"Kuan","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0265","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1084\/jem.181.3.1123","article-title":"Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity","volume":"181","author":"Liao","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0270","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.4049\/jimmunol.148.12.3806","article-title":"In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis","volume":"148","author":"Neumann","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0275","doi-asserted-by":"crossref","first-page":"8234","DOI":"10.4049\/jimmunol.177.11.8234","article-title":"Mimicry and antibody-mediated cell signaling in autoimmune myocarditis","volume":"177","author":"Li","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0280","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.4049\/jimmunol.166.10.6423","article-title":"Calreticulin, a potential cell surface receptor involved in cell penetration of anti-DNA antibodies","volume":"166","author":"Seddiki","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0285","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1096\/fj.04-3001com","article-title":"Human cardiac myosin autoantibodies impair myocyte contractility: a cause-and-effect relationship","volume":"20","author":"Warraich","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0290","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.92.6.1487","article-title":"Expression and functional significance of tumor necrosis factor receptors in human myocardium","volume":"92","author":"Torre-Amione","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0295","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0735-1097(97)00494-4","article-title":"Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure","volume":"31","author":"Tsutamoto","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0300","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/415206a","article-title":"Seven-transmembrane-spanning receptors and heart function","volume":"415","author":"Rockman","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0305","doi-asserted-by":"crossref","first-page":"34528","DOI":"10.1074\/jbc.M002844200","article-title":"beta-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes","volume":"275","author":"Saito","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0310","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI200420149","article-title":"Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy","volume":"113","author":"Jahns","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0315","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI21748","article-title":"Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation","volume":"113","author":"Freedman","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0320","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/B:MCBI.0000021380.97941.78","article-title":"Cardioprotective effects of carvedilol on acute autoimmune myocarditis","volume":"259","author":"Yuan","year":"2004","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0325","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11596-010-0546-x","article-title":"Induction of cardiomyocyte apoptosis by anti-cardiac myosin heavy chain antibodies in patients with acute myocardial infarction","volume":"30","author":"Liu","year":"2010","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0330","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.106.655076","article-title":"Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure","volume":"116","author":"Latini","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.crd.0000089981.53961.cf","article-title":"Cardiac troponin levels in heart failure","volume":"12","author":"Potluri","year":"2004","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0340","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2147\/CIA.S3551","article-title":"Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and Gensini score: a hospital-based, prospective study in Greek patients","volume":"3","author":"Peppes","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0345","first-page":"423","article-title":"Correlation of cardiac troponin I levels (10 folds upper limit of normal) and extent of coronary artery disease in non-ST elevation myocardial infarction","volume":"60","author":"Qadir","year":"2010","journal-title":"J. Pak. Med. Assoc."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0350","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/01.CIR.92.3.334","article-title":"Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality","volume":"92","author":"Miller","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0355","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0002-9149(99)00529-9","article-title":"Comparison of acute myocardial infarct size to two-year mortality in patients \u226565 to those \u226565years of age","volume":"84","author":"Miller","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0360","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/oxfordjournals.eurheartj.a060045","article-title":"Left ventricular aneurysm and prognosis in patients with first acute transmural anterior myocardial infarction and isolated left anterior descending artery disease","volume":"13","author":"Shen","year":"1992","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0365","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.cca.2010.08.005","article-title":"Autoantibodies to cardiac troponin in acute coronary syndromes","volume":"411","author":"Lindahl","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0370","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10238-011-0141-x","article-title":"Multiple immunoassay systems are negatively interfered by circulating cardiac troponin I autoantibodies","volume":"12","author":"Tang","year":"2012","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0375","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/eurheartj\/ehn268","article-title":"Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction","volume":"29","author":"Leuschner","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0380","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1373\/clinchem.2008.115469","article-title":"Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients","volume":"55","author":"Pettersson","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0385","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2796.2007.01881.x","article-title":"Antitissue transglutaminase antibodies in acute coronary syndrome: an alert signal of myocardial tissue lesion?","volume":"263","author":"Tola","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/14017431003797168","article-title":"Anti-endothelial cell antibodies are increased in patients with previous myocardial infarction","volume":"44","author":"Elsheikh","year":"2010","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0395","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0021-9150(00)00482-2","article-title":"Activation of the immune system and coronary heart artery disease: The role of anti-endothelial cell antibodies","volume":"154","author":"Farsi","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0400","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1745-7270.2006.00185.x","article-title":"Autoantibody against cardiac beta1-adrenoceptor induces apoptosis in cultured neonatal rat cardiomyocytes","volume":"38","author":"Gao","year":"2006","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0405","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/CIRCULATIONAHA.106.683193","article-title":"Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis","volume":"116","author":"Jane-wit","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0410","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.RES.88.6.578","article-title":"Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo","volume":"88","author":"Iwata","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0415","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(00)00568-4","article-title":"Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study","volume":"35","author":"Felix","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0420","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijcard.2003.12.003","article-title":"Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy","volume":"97","author":"Knebel","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0425","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/01.CIR.103.22.2681","article-title":"Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution","volume":"103","author":"Staudt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0430","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.CIR.103.2.220","article-title":"Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure","volume":"103","author":"Gullestad","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0435","first-page":"479","article-title":"Prednisone-induced alterations of circulating human lymphocyte subsets","volume":"101","author":"Slade","year":"1983","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0440","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4049\/jimmunol.132.1.170","article-title":"Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids","volume":"132","author":"Cupps","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0445","first-page":"204","article-title":"Deleterious effects of methylprednisolone in patients with myocardial infarction","author":"Roberts","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0450","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9149(03)00148-6","article-title":"Meta-analysis of corticosteroid treatment in acute myocardial infarction","author":"Giugliano","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0455","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.97.22.2259","article-title":"Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy","volume":"97","author":"Vakeva","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0460","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-5890(96)00078-8","article-title":"Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv","volume":"33","author":"Thomas","year":"1996","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0465","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1161\/01.CIR.100.25.2499","article-title":"Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass","volume":"100","author":"Fitch","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0470","first-page":"49","article-title":"Current trials in acute myocardial infarction","volume":"7","author":"Bahit","year":"2001","journal-title":"Cardiol. Spec. Ed."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0475","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomised Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0480","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.pharmtox.40.1.283","article-title":"Pharmacology of selectin inhibitors in ischemia\/reperfusion states","volume":"40","author":"Lefer","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0485","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-3565(25)22698-2","article-title":"Humanized monoclonal antibody DREG-200 directed against L-selectin protects in feline myocardial reperfusion injury","volume":"271","author":"Buerke","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0490","first-page":"79","article-title":"Monoclonal antibody to intercellular adhesion molecule-1, but not to endothelial-leukocyte adhesion molecule-1, protects against myocardial ischemia\/reperfusion damage in anesthetized monkeys","volume":"86","author":"Winquist","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0495","first-page":"763","article-title":"Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart","volume":"46","author":"Jones","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0500","doi-asserted-by":"crossref","first-page":"37069","DOI":"10.1074\/jbc.M103574200","article-title":"A novel role for interleukin-18 in adhesion molecule induction through NF-\u03baB and phophatidylinositol (PI) 3-kinase-dependent signal transduction pathways","volume":"276","author":"Morel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0505","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/08916934.2011.647134","article-title":"The autoimmune nature of post-infarct myocardial healing: oral tolerance to cardiac antigens as a novel strategy to improve cardiac healing","volume":"45","author":"Ramos","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ijcard.2016.02.035_bb0510","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/intimm\/dxp051","article-title":"Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia\u2013reperfusion injury","volume":"21","author":"Frenkel","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ijcard.2016.02.035_bb0515","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s10875-009-9290-z","article-title":"Oral tolerization with cardiac myosin peptide (614\u2013629) ameliorates experimental autoimmune myocarditis: role of STAT 6 genes in BALB\/CJ mice","volume":"29","author":"Gonnella","year":"2009","journal-title":"J. Clin. Immunol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316302492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316302492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T09:02:24Z","timestamp":1748768544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316302492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":103,"alternative-id":["S0167527316302492"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.02.035","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of anti-myosin antibodies in perpetuating cardiac damage following myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2016 Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}